7 Recent reports on IBD

7 Recent reports on IBD

Healio Gastroenterology presents the following account of our latest inflammatory bowel disease coverage.These stories include topics regarding COVID-19 and IBD, therapeutic research, a preview of the ACG Annual Scientific Meeting and more.Though there is no significant difference in COVID-19 infection rates among patients with inflammatory bowel disease compared with the general public, some IBD therapies correlated with increased infection severity.“The therapies for IBD are predominantly immune-based, immune modifying and sometimes immune suppressive,” David T. Rubin, MD, FACG,Read More

Share on facebook
Share on twitter
Share on linkedin